| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |